![syringe](http://www.4bonehealth.org/wp-content/uploads/2012/03/syringe-300x100.png)
On the heels of the European Union’s approval, the FDA announced today approval of Amgen’s osteoporosis drug Prolia™ (denosumab) for treatment of postmenopausal women with osteoporosis. We were expecting news later in the summer, so this early announcement was a surprise. Prolia™ is given in your doctor’s office as a shot under the skin twice… Read more